-
House of Lords raises urgent question on reintroducing COVID-19 restrictions | 20 October 2021
Watch members of the House of Lords press the government on rising COVID-19 cases and the triggers to implement Plan B.
Topics:
00:00 – Ministers first response
01:09 – Stopping future lockdowns
02:11 – Preventing an NHS winter crisis
03:32 – COVID-19 hospital patients
04:09 – Setting good examples
05:12 – COVID-19 inequalities
06:02 – Government advisors
06:37 – Wearing masks
07:47 – Encouraging the public to act responsibly
08:43 – Uptake of the booster jab
09:22 – Government response time to COVID-19
10:26 – The impact of lockdowns
11:29 – Consulting with the devolved administrations
12:05 – Impact of COVID-19 on those with disabilities
12:57 – Advice from SAGE
13:14 – COVID-19 decision making
13:56 – COVID-19 related deaths
14:35 – Statistics
Read a transcript of this ...
published: 26 Oct 2021
-
Coronavirus vaccine: Why does it take so long? (COVID-19) - Doctor Explains
Why does it takes so long to make a vaccine for the Coronavirus? Bluntly, because it is incredibly hard to do and if mistakes are made a vaccine can be dangerous!
Now let’s start with the question "what is a vaccine?" A vaccine is a biological preparation that provides active acquired immunity to a particular infectious disease. Or in other words it’s a medicine which makes you immune to a certain disease.
A vaccine contains bacteria or a virus in a weakened state, death state or in very little amounts. The idea here is that this bacteria or virus can’t actually make you sick, but does start an immune respons. Through this immune response you build immunity. So when you would later encounter the “real” bacteria or virus, your immune system is ready for it. And it will eradicate the virus...
published: 14 Apr 2020
-
Covid-19: What you need to know about child vaccines
The roll out of Pfizer's paediatric Covid-19 vaccine for children is beginning on January 17 and those aged 5 to 11 will have a chance to get a dose and reduce the risks of the virus.
Full story: https://bit.ly/3A2EcdR
Subscribe and be notified of breaking news: https://goo.gl/LP45jX
Check out our playlists: https://goo.gl/Swd249
Like NZ Herald on Facebook: https://goo.gl/tUC4oq
Follow NZ Herald on Instagram: https://goo.gl/oLicXe
Follow NZ Herald on Twitter: https://goo.gl/Wi6mbv
published: 16 Jan 2022
-
China’s Fosun Pharma working on Omicron-specific vaccine #Shorts
China’s Fosun Pharma working on Omicron-specific vaccine #Shorts
Fosun Pharmaceutical it is working with German partner BioNTech SE to develop a new vaccine targeting the Omicron variant of coronavirus. The chief executive of Fosun Pharma has told a vaccine summit in Shenzhen that a vaccine dealing with the new variant could be developed in 6 weeks if necessary, though it could take from 3 to 4 months to win regulatory approval. He cited a report released by Israel last month saying current mRNA vaccines made by BioNTech are giving a 90 percent protection rate against Omicron variant infections.
----- For more info about me -----
Based in Shanghai, we follow the latest polices and trend, and explores detailed stories on doing business. SUBSCRIBE to our channel to be among the first t...
published: 09 Dec 2021
-
Salk (disambiguation)
Jonas Salk (1914–1995) was the developer of the first effective polio vaccine.
Salk may also refer to:
Designation for the inactivated (dead) poliovirus form of polio vaccine
Lee Salk (1926–1992), psychologist and author
Salk Institute for Biological Studies, a research institute in La Jolla, California, USA
Salk School of Science, middle school in Manhattan
Salk Hall
Source: https://en.wikipedia.org/wiki/Salk_(disambiguation)
Created with WikipediaReaderReborn (c) WikipediaReader
published: 09 Nov 2021
-
Building Digital Infrastructure to Ensure Supply of Vaccines and Timely Vaccination | Panel 4 |
Follow us on our fb page at:
https://www.facebook.com/FABA_Academy-106117117773796/
We welcome you to the series of videos with the proceedings of the conference recently held on the theme " Supply Chain Challenges of COVID-19 Vaccines: Indian Imperative"
Watch these, to enlighten yourselves with how the government is prepared for the distribution of Covid-19 vaccine across India!
published: 01 Dec 2020
-
Leveraging Natural Language Processing in Pharma R&D - Peter Henstock of Pfizer
Watch & Listen to our distinguished speaker, Dr Peter Henstock discuss Leveraging Natural Language Processing in Pharma R&D
This presentation was delivered at the Virtual Precision in Drug Discovery & Preclinical Summit (Europe) on October 6th-7th, 2021.
For our future In-Person and Hybrid Summit events please routinely check: https://events.precision-globe.com/ and Follow us on LinkedIn and Twitter for future updates!
For those that had to miss it, you can email [email protected] to gain information that will change the way you think of Scientific Research.
#PCT #PrecisionEvents #vaccine #VirtualPDDP
#flattenthecurve #PDDP
#DrugDiscovery #preclinical #covid19
#coronavirus #HTS #drugdevelopment
#pharmaceuticals #biotechnology #cance...
published: 04 Nov 2021
-
Ranking effectiveness of worldwide COVID19 government interventions-Alessandro Londei | Etincelle #4
Assessing non-pharmaceutical interventions’ (NPIs) effectiveness to mitigate the spread of SARS-CoV-2 is critical to inform future preparedness response plans. We propose a modeling approach that combines four computational techniques merging statistical, inference, and artificial intelligence tools to evaluate the impact of NPIs on spreading the Covid19 pandemic. Our results indicate that a suitable combination of NPIs is necessary to curb the spread of the virus. Less disruptive and costly NPIs can be as effective as more intrusive, drastic ones (for example, a national lockdown). Using country-specific “what-if” scenarios, we assess how the effectiveness of NPIs depends on the local context, such as the timing of their adoption, opening the way for forecasting the effectiveness of futur...
published: 22 Jan 2021
-
How can we improve our model? | Modeling the Pandemic, chapter 3
The WAIFW Matrix image is from "Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales" by Pitman et al. (2011)
For more information on the WAIFW, see
https://www.amazon.com/Introduction-Infectious-Disease-Modelling-ebook/dp/B00DUDQ07G
published: 12 Mar 2020
-
COVID Authors Griffin Weber
published: 06 Jul 2021
-
Estimating the multiplicity of infection of P. falciporum malaria parasites
If you're unlucky enough to be infected by malaria, you might even be infected by multiple strains of malaria! So how can we monitor whether interventions against this deadly disease are working? This talk discusses a research collaboration between Emory University and the CDC about methods that might help.
published: 09 Nov 2017
-
The European Health Union & access to health technologies: is joint purchasing the way forward?
The European Health Union & access to health technologies: is joint purchasing the way forward?
Thursday, 10 February 2022 (12:00- 13:00 CET)
This 60-minute session is the first of a European Health Union Initiative webinar series with the European Observatory on Health Systems and Policies, organised in close cooperation European Health Forum Gastein.
The enduring problem of ensuring sustainable and equitable access to affordable medicines and other health technologies for all has been highlighted once again during the COVID-19 crisis. In this upcoming webinar organised in close collaboration between the European Health Union initiative and the European Observatory on Health Systems and Policies, we will explore whether we can harness the recent experience of joint purchasing during t...
published: 11 Feb 2022
-
Columbia NLP Seminar (Liang Huang): Parsing Algorithms for COVID-19
Columbia University NLP Seminar, April 19, 2022 (missing the first 5 minutes of recording)
Two Sides of the Same Coin: Parsing Algorithms for COVID-19
Liang Huang (Baidu Research USA & Oregon State University)
Abstract: Linguistics and biology are seemingly very different, but they actually share the same mathematical foundations. In particular, many algorithms have been reinvented in both NLP and computational biology, including CKY and Inside-Outside. This talk will cover several success stories of applying efficient natural language parsing algorithms to speed up RNA biology, and showcase their impact on COVID-19.
We start by adapting the linear-time incremental parsing algorithm of Huang and Sagae (2010) to RNA folding, which results in LinearFold (2019), the first major speedup in ...
published: 21 Apr 2022
-
Viruses and the Tree of Life
This video discusses viral infections, viral structure and the relationship of viruses to the tree of life. A mathematical model is used to predict when the travel restrictions now in effect for the COVID-19 Corona Virus may be lifted.
Resources:
Johns Hopkins Coronavirus Resource Center
https://coronavirus.jhu.edu/map.html
Ben Sparks describes a model to predict the propagation of cornavirus (COVID-19).
https://youtu.be/k6nLfCbAzgo
published: 31 Mar 2020
15:51
House of Lords raises urgent question on reintroducing COVID-19 restrictions | 20 October 2021
Watch members of the House of Lords press the government on rising COVID-19 cases and the triggers to implement Plan B.
Topics:
00:00 – Ministers first respon...
Watch members of the House of Lords press the government on rising COVID-19 cases and the triggers to implement Plan B.
Topics:
00:00 – Ministers first response
01:09 – Stopping future lockdowns
02:11 – Preventing an NHS winter crisis
03:32 – COVID-19 hospital patients
04:09 – Setting good examples
05:12 – COVID-19 inequalities
06:02 – Government advisors
06:37 – Wearing masks
07:47 – Encouraging the public to act responsibly
08:43 – Uptake of the booster jab
09:22 – Government response time to COVID-19
10:26 – The impact of lockdowns
11:29 – Consulting with the devolved administrations
12:05 – Impact of COVID-19 on those with disabilities
12:57 – Advice from SAGE
13:14 – COVID-19 decision making
13:56 – COVID-19 related deaths
14:35 – Statistics
Read a transcript of this event:
https://hansard.parliament.uk/lords/2021-10-20/debates/B2FEDC6A-93FA-40DF-9616-B340589EB799/Covid-19PlanB
Catch-up on House of Lords business:
Watch live events: https://parliamentlive.tv/Lords
Read the latest news: https://www.parliament.uk/lords/
Stay up to date with the House of Lords on social media:
• Twitter: https://twitter.com/UKHouseofLords
• Instagram: https://www.instagram.com/UKHouseofLords/
• Facebook: https://www.facebook.com/UKHouseofLords
• Flickr: https://flickr.com/photos/ukhouseoflords/albums
• LinkedIn: https://www.linkedin.com/company/the-house-of-lords
#HouseofLords #UKParliament
https://wn.com/House_Of_Lords_Raises_Urgent_Question_On_Reintroducing_Covid_19_Restrictions_|_20_October_2021
Watch members of the House of Lords press the government on rising COVID-19 cases and the triggers to implement Plan B.
Topics:
00:00 – Ministers first response
01:09 – Stopping future lockdowns
02:11 – Preventing an NHS winter crisis
03:32 – COVID-19 hospital patients
04:09 – Setting good examples
05:12 – COVID-19 inequalities
06:02 – Government advisors
06:37 – Wearing masks
07:47 – Encouraging the public to act responsibly
08:43 – Uptake of the booster jab
09:22 – Government response time to COVID-19
10:26 – The impact of lockdowns
11:29 – Consulting with the devolved administrations
12:05 – Impact of COVID-19 on those with disabilities
12:57 – Advice from SAGE
13:14 – COVID-19 decision making
13:56 – COVID-19 related deaths
14:35 – Statistics
Read a transcript of this event:
https://hansard.parliament.uk/lords/2021-10-20/debates/B2FEDC6A-93FA-40DF-9616-B340589EB799/Covid-19PlanB
Catch-up on House of Lords business:
Watch live events: https://parliamentlive.tv/Lords
Read the latest news: https://www.parliament.uk/lords/
Stay up to date with the House of Lords on social media:
• Twitter: https://twitter.com/UKHouseofLords
• Instagram: https://www.instagram.com/UKHouseofLords/
• Facebook: https://www.facebook.com/UKHouseofLords
• Flickr: https://flickr.com/photos/ukhouseoflords/albums
• LinkedIn: https://www.linkedin.com/company/the-house-of-lords
#HouseofLords #UKParliament
- published: 26 Oct 2021
- views: 4686
4:32
Coronavirus vaccine: Why does it take so long? (COVID-19) - Doctor Explains
Why does it takes so long to make a vaccine for the Coronavirus? Bluntly, because it is incredibly hard to do and if mistakes are made a vaccine can be dangerou...
Why does it takes so long to make a vaccine for the Coronavirus? Bluntly, because it is incredibly hard to do and if mistakes are made a vaccine can be dangerous!
Now let’s start with the question "what is a vaccine?" A vaccine is a biological preparation that provides active acquired immunity to a particular infectious disease. Or in other words it’s a medicine which makes you immune to a certain disease.
A vaccine contains bacteria or a virus in a weakened state, death state or in very little amounts. The idea here is that this bacteria or virus can’t actually make you sick, but does start an immune respons. Through this immune response you build immunity. So when you would later encounter the “real” bacteria or virus, your immune system is ready for it. And it will eradicate the virus or bacteria quickly, without you becoming terribly ill.
Unfortunately it takes a long time to make an vaccine. For example the vaccine against SARS in 2003 took 20 months before it could be tested on humans.
It takes so long because making a safe and effective vaccine requires a lot of steps and testing.
Now first off the virus needs to be weakened, but not too much because there still needs to be an immune response. Next up it needs to be tested on lab animals. Usually mice. This takes approximately 3 months. Afterwards the vaccine needs to be tested on apes, because their DNA is closest to human DNA. And therefore their immune systems responds closely to ours. This process also takes about 3 months. After these 3 months we need to observe if the immunity the vaccine gave the apes remains persistent.
Luckily there is also some good news here. The coronavirus seems to be a very stable virus. This makes it way easier to produce a vaccine which will give us persistent immunity.
The next step is purifying the vaccine and making it safe; we are talking purity, quality and dosage. This is especially important because the production of the vaccine will be increased.
At first it is made in a lab, but once ready it will be produced in a bioreactor. During this step many choices need to be made. For example in which form you want to offer the vaccine; liquid or lyophilized?
So you can imagine it takes a while before a vaccine is mass-produced and available. That is why most experts estimate it can take upwards of 1 to even 2 years from now until a vaccine will be available.
This brings us to the coronavirus vaccines which are currently developed all over the world. There currently are tens of trails in different stages of their development. Which is many to discuss here in this video. The important part is that among these trails some have the potential to eventually develop an effective and safe vaccine.
However which trail and when, can’t possibly be said at time time. But I will keep you updated. As soon as any of these trails show tremendous results I will let you know.
For now it is important we educate ourselves on the coronavirus, so we can stay as safe as possible. You can do this by watching my playlist containing everything you need to know on the coronavirus. You can find these videos here:
1. Coronavirus the numbers: https://youtu.be/lMHi5CBJoLQ
2. FAQ coronavirus: https://youtu.be/KIJMFSpLzQ8
3. Stop the spread: https://youtu.be/QX9YeVPC7w4
4. Curing the Coronavirus: https://youtu.be/Q3vfj4kcul4
Coronavirus playlist: https://www.youtube.com/watch?v=KIJMFSpLzQ8&list=PLaG3Bo3L0gX4M4gomuYMNR1MdlNWWkk6A
Thanks for watching and make sure to subscribe for future videos on medication and medical topics!
- Disclaimer: this video is meant purely informational! This is not medical advice! If you are looking for medical advice always contact your own doctor. -
Literature:
1: RIVM. (2020). Nieuw coronavirus (COVID-19).
2: CDC. (2020). Coronavirus (COVID-19).
3: Duddu P. (2020). Coronavirus treatment: Vaccines/drugs in the pipeline for COVID-19.
4: Nu.nl (2020) Waarom duurt het zo lang om een vaccin tegen corona te maken? | NU.nl.
* The images in this video are used for educational purposes only.
Music:
1: Divkid. Dusk
2: Emily A. Sprague. Meeting Again
3: Ikson, New Day
Follow me on instagram: @HowtoMedicate
Follow me on twitter: @HowtoMedicate
Books I used In Medical School:
Lehninger Principles of Biochemistry, https://amzn.to/2PFGidh
Guyton and Hall Textbook of Medical Physiology, https://amzn.to/3inL6jM
Human Anatomy & Physiology, https://amzn.to/2DHlHCT
Oxford Handbook of Clinical Specialties, https://amzn.to/3fU854s
Atlas of Human Anatomy, https://amzn.to/3afFe9c
Gear I use:
Camera: Canon EOS M50: https://amzn.to/33SNMSn
Microphone: Rode VideoMicPro: https://amzn.to/3amCmrh
Computer: Apple Macbook Pro: https://amzn.to/33PDEtu
https://wn.com/Coronavirus_Vaccine_Why_Does_It_Take_So_Long_(Covid_19)_Doctor_Explains
Why does it takes so long to make a vaccine for the Coronavirus? Bluntly, because it is incredibly hard to do and if mistakes are made a vaccine can be dangerous!
Now let’s start with the question "what is a vaccine?" A vaccine is a biological preparation that provides active acquired immunity to a particular infectious disease. Or in other words it’s a medicine which makes you immune to a certain disease.
A vaccine contains bacteria or a virus in a weakened state, death state or in very little amounts. The idea here is that this bacteria or virus can’t actually make you sick, but does start an immune respons. Through this immune response you build immunity. So when you would later encounter the “real” bacteria or virus, your immune system is ready for it. And it will eradicate the virus or bacteria quickly, without you becoming terribly ill.
Unfortunately it takes a long time to make an vaccine. For example the vaccine against SARS in 2003 took 20 months before it could be tested on humans.
It takes so long because making a safe and effective vaccine requires a lot of steps and testing.
Now first off the virus needs to be weakened, but not too much because there still needs to be an immune response. Next up it needs to be tested on lab animals. Usually mice. This takes approximately 3 months. Afterwards the vaccine needs to be tested on apes, because their DNA is closest to human DNA. And therefore their immune systems responds closely to ours. This process also takes about 3 months. After these 3 months we need to observe if the immunity the vaccine gave the apes remains persistent.
Luckily there is also some good news here. The coronavirus seems to be a very stable virus. This makes it way easier to produce a vaccine which will give us persistent immunity.
The next step is purifying the vaccine and making it safe; we are talking purity, quality and dosage. This is especially important because the production of the vaccine will be increased.
At first it is made in a lab, but once ready it will be produced in a bioreactor. During this step many choices need to be made. For example in which form you want to offer the vaccine; liquid or lyophilized?
So you can imagine it takes a while before a vaccine is mass-produced and available. That is why most experts estimate it can take upwards of 1 to even 2 years from now until a vaccine will be available.
This brings us to the coronavirus vaccines which are currently developed all over the world. There currently are tens of trails in different stages of their development. Which is many to discuss here in this video. The important part is that among these trails some have the potential to eventually develop an effective and safe vaccine.
However which trail and when, can’t possibly be said at time time. But I will keep you updated. As soon as any of these trails show tremendous results I will let you know.
For now it is important we educate ourselves on the coronavirus, so we can stay as safe as possible. You can do this by watching my playlist containing everything you need to know on the coronavirus. You can find these videos here:
1. Coronavirus the numbers: https://youtu.be/lMHi5CBJoLQ
2. FAQ coronavirus: https://youtu.be/KIJMFSpLzQ8
3. Stop the spread: https://youtu.be/QX9YeVPC7w4
4. Curing the Coronavirus: https://youtu.be/Q3vfj4kcul4
Coronavirus playlist: https://www.youtube.com/watch?v=KIJMFSpLzQ8&list=PLaG3Bo3L0gX4M4gomuYMNR1MdlNWWkk6A
Thanks for watching and make sure to subscribe for future videos on medication and medical topics!
- Disclaimer: this video is meant purely informational! This is not medical advice! If you are looking for medical advice always contact your own doctor. -
Literature:
1: RIVM. (2020). Nieuw coronavirus (COVID-19).
2: CDC. (2020). Coronavirus (COVID-19).
3: Duddu P. (2020). Coronavirus treatment: Vaccines/drugs in the pipeline for COVID-19.
4: Nu.nl (2020) Waarom duurt het zo lang om een vaccin tegen corona te maken? | NU.nl.
* The images in this video are used for educational purposes only.
Music:
1: Divkid. Dusk
2: Emily A. Sprague. Meeting Again
3: Ikson, New Day
Follow me on instagram: @HowtoMedicate
Follow me on twitter: @HowtoMedicate
Books I used In Medical School:
Lehninger Principles of Biochemistry, https://amzn.to/2PFGidh
Guyton and Hall Textbook of Medical Physiology, https://amzn.to/3inL6jM
Human Anatomy & Physiology, https://amzn.to/2DHlHCT
Oxford Handbook of Clinical Specialties, https://amzn.to/3fU854s
Atlas of Human Anatomy, https://amzn.to/3afFe9c
Gear I use:
Camera: Canon EOS M50: https://amzn.to/33SNMSn
Microphone: Rode VideoMicPro: https://amzn.to/3amCmrh
Computer: Apple Macbook Pro: https://amzn.to/33PDEtu
- published: 14 Apr 2020
- views: 440
2:10
Covid-19: What you need to know about child vaccines
The roll out of Pfizer's paediatric Covid-19 vaccine for children is beginning on January 17 and those aged 5 to 11 will have a chance to get a dose and reduce ...
The roll out of Pfizer's paediatric Covid-19 vaccine for children is beginning on January 17 and those aged 5 to 11 will have a chance to get a dose and reduce the risks of the virus.
Full story: https://bit.ly/3A2EcdR
Subscribe and be notified of breaking news: https://goo.gl/LP45jX
Check out our playlists: https://goo.gl/Swd249
Like NZ Herald on Facebook: https://goo.gl/tUC4oq
Follow NZ Herald on Instagram: https://goo.gl/oLicXe
Follow NZ Herald on Twitter: https://goo.gl/Wi6mbv
https://wn.com/Covid_19_What_You_Need_To_Know_About_Child_Vaccines
The roll out of Pfizer's paediatric Covid-19 vaccine for children is beginning on January 17 and those aged 5 to 11 will have a chance to get a dose and reduce the risks of the virus.
Full story: https://bit.ly/3A2EcdR
Subscribe and be notified of breaking news: https://goo.gl/LP45jX
Check out our playlists: https://goo.gl/Swd249
Like NZ Herald on Facebook: https://goo.gl/tUC4oq
Follow NZ Herald on Instagram: https://goo.gl/oLicXe
Follow NZ Herald on Twitter: https://goo.gl/Wi6mbv
- published: 16 Jan 2022
- views: 2935
0:32
China’s Fosun Pharma working on Omicron-specific vaccine #Shorts
China’s Fosun Pharma working on Omicron-specific vaccine #Shorts
Fosun Pharmaceutical it is working with German partner BioNTech SE to develop a new vaccine ...
China’s Fosun Pharma working on Omicron-specific vaccine #Shorts
Fosun Pharmaceutical it is working with German partner BioNTech SE to develop a new vaccine targeting the Omicron variant of coronavirus. The chief executive of Fosun Pharma has told a vaccine summit in Shenzhen that a vaccine dealing with the new variant could be developed in 6 weeks if necessary, though it could take from 3 to 4 months to win regulatory approval. He cited a report released by Israel last month saying current mRNA vaccines made by BioNTech are giving a 90 percent protection rate against Omicron variant infections.
----- For more info about me -----
Based in Shanghai, we follow the latest polices and trend, and explores detailed stories on doing business. SUBSCRIBE to our channel to be among the first to touch the business pulse of Shanghai.
- Website: http://www.kankanews.com/
- Facebook: https://www.facebook.com/icsmoneytalks
- Podcast: https://apple.co/32SZWJ8
https://wn.com/China’S_Fosun_Pharma_Working_On_Omicron_Specific_Vaccine_Shorts
China’s Fosun Pharma working on Omicron-specific vaccine #Shorts
Fosun Pharmaceutical it is working with German partner BioNTech SE to develop a new vaccine targeting the Omicron variant of coronavirus. The chief executive of Fosun Pharma has told a vaccine summit in Shenzhen that a vaccine dealing with the new variant could be developed in 6 weeks if necessary, though it could take from 3 to 4 months to win regulatory approval. He cited a report released by Israel last month saying current mRNA vaccines made by BioNTech are giving a 90 percent protection rate against Omicron variant infections.
----- For more info about me -----
Based in Shanghai, we follow the latest polices and trend, and explores detailed stories on doing business. SUBSCRIBE to our channel to be among the first to touch the business pulse of Shanghai.
- Website: http://www.kankanews.com/
- Facebook: https://www.facebook.com/icsmoneytalks
- Podcast: https://apple.co/32SZWJ8
- published: 09 Dec 2021
- views: 160
0:38
Salk (disambiguation)
Jonas Salk (1914–1995) was the developer of the first effective polio vaccine.
Salk may also refer to:
Designation for the inactivated (dead) poliovirus form o...
Jonas Salk (1914–1995) was the developer of the first effective polio vaccine.
Salk may also refer to:
Designation for the inactivated (dead) poliovirus form of polio vaccine
Lee Salk (1926–1992), psychologist and author
Salk Institute for Biological Studies, a research institute in La Jolla, California, USA
Salk School of Science, middle school in Manhattan
Salk Hall
Source: https://en.wikipedia.org/wiki/Salk_(disambiguation)
Created with WikipediaReaderReborn (c) WikipediaReader
https://wn.com/Salk_(Disambiguation)
Jonas Salk (1914–1995) was the developer of the first effective polio vaccine.
Salk may also refer to:
Designation for the inactivated (dead) poliovirus form of polio vaccine
Lee Salk (1926–1992), psychologist and author
Salk Institute for Biological Studies, a research institute in La Jolla, California, USA
Salk School of Science, middle school in Manhattan
Salk Hall
Source: https://en.wikipedia.org/wiki/Salk_(disambiguation)
Created with WikipediaReaderReborn (c) WikipediaReader
- published: 09 Nov 2021
- views: 1
54:56
Building Digital Infrastructure to Ensure Supply of Vaccines and Timely Vaccination | Panel 4 |
Follow us on our fb page at:
https://www.facebook.com/FABA_Academy-106117117773796/
We welcome you to the series of videos with the proceedings of the confe...
Follow us on our fb page at:
https://www.facebook.com/FABA_Academy-106117117773796/
We welcome you to the series of videos with the proceedings of the conference recently held on the theme " Supply Chain Challenges of COVID-19 Vaccines: Indian Imperative"
Watch these, to enlighten yourselves with how the government is prepared for the distribution of Covid-19 vaccine across India!
https://wn.com/Building_Digital_Infrastructure_To_Ensure_Supply_Of_Vaccines_And_Timely_Vaccination_|_Panel_4_|
Follow us on our fb page at:
https://www.facebook.com/FABA_Academy-106117117773796/
We welcome you to the series of videos with the proceedings of the conference recently held on the theme " Supply Chain Challenges of COVID-19 Vaccines: Indian Imperative"
Watch these, to enlighten yourselves with how the government is prepared for the distribution of Covid-19 vaccine across India!
- published: 01 Dec 2020
- views: 26
29:39
Leveraging Natural Language Processing in Pharma R&D - Peter Henstock of Pfizer
Watch & Listen to our distinguished speaker, Dr Peter Henstock discuss Leveraging Natural Language Processing in Pharma R&D
This presentation was delivered at...
Watch & Listen to our distinguished speaker, Dr Peter Henstock discuss Leveraging Natural Language Processing in Pharma R&D
This presentation was delivered at the Virtual Precision in Drug Discovery & Preclinical Summit (Europe) on October 6th-7th, 2021.
For our future In-Person and Hybrid Summit events please routinely check: https://events.precision-globe.com/ and Follow us on LinkedIn and Twitter for future updates!
For those that had to miss it, you can email
[email protected] to gain information that will change the way you think of Scientific Research.
#PCT #PrecisionEvents #vaccine #VirtualPDDP
#flattenthecurve #PDDP
#DrugDiscovery #preclinical #covid19
#coronavirus #HTS #drugdevelopment
#pharmaceuticals #biotechnology #cancer
#science #informatics #oncology
#cardio #alzheimers #discoveryoutsourcingservices
#hittolead #chemistry #biopharma
#pharma #biotech #Opioids
#pipeline #researchanddevelopement #genomics
#therapeutics #medicines #medicinalchemistry #innovation #summit #event #CNS #Therapeutics
Add on
Main Channel: https://www.youtube.com/channel/UCNQZ...
Official Website: http://www.precision-globe.com
Linkedin: https://www.linkedin.com/company/prec...
Twitter: https://twitter.com/PrecisionEvolu1
https://wn.com/Leveraging_Natural_Language_Processing_In_Pharma_R_D_Peter_Henstock_Of_Pfizer
Watch & Listen to our distinguished speaker, Dr Peter Henstock discuss Leveraging Natural Language Processing in Pharma R&D
This presentation was delivered at the Virtual Precision in Drug Discovery & Preclinical Summit (Europe) on October 6th-7th, 2021.
For our future In-Person and Hybrid Summit events please routinely check: https://events.precision-globe.com/ and Follow us on LinkedIn and Twitter for future updates!
For those that had to miss it, you can email
[email protected] to gain information that will change the way you think of Scientific Research.
#PCT #PrecisionEvents #vaccine #VirtualPDDP
#flattenthecurve #PDDP
#DrugDiscovery #preclinical #covid19
#coronavirus #HTS #drugdevelopment
#pharmaceuticals #biotechnology #cancer
#science #informatics #oncology
#cardio #alzheimers #discoveryoutsourcingservices
#hittolead #chemistry #biopharma
#pharma #biotech #Opioids
#pipeline #researchanddevelopement #genomics
#therapeutics #medicines #medicinalchemistry #innovation #summit #event #CNS #Therapeutics
Add on
Main Channel: https://www.youtube.com/channel/UCNQZ...
Official Website: http://www.precision-globe.com
Linkedin: https://www.linkedin.com/company/prec...
Twitter: https://twitter.com/PrecisionEvolu1
- published: 04 Nov 2021
- views: 209
54:58
Ranking effectiveness of worldwide COVID19 government interventions-Alessandro Londei | Etincelle #4
Assessing non-pharmaceutical interventions’ (NPIs) effectiveness to mitigate the spread of SARS-CoV-2 is critical to inform future preparedness response plans. ...
Assessing non-pharmaceutical interventions’ (NPIs) effectiveness to mitigate the spread of SARS-CoV-2 is critical to inform future preparedness response plans. We propose a modeling approach that combines four computational techniques merging statistical, inference, and artificial intelligence tools to evaluate the impact of NPIs on spreading the Covid19 pandemic. Our results indicate that a suitable combination of NPIs is necessary to curb the spread of the virus. Less disruptive and costly NPIs can be as effective as more intrusive, drastic ones (for example, a national lockdown). Using country-specific “what-if” scenarios, we assess how the effectiveness of NPIs depends on the local context, such as the timing of their adoption, opening the way for forecasting the effectiveness of future interventions.
Etincelle #4 - January 20, 2021
Alessandro Londei has a degree in Physics and a PhD in Electronic Engineering and Computer Science at the Sapienza University of Rome. During his professional career he has been involved in complex systems, neural networks, cognitive sciences and artificial intelligence. He held the courses of Neural Networks and Artificial Intelligence at the Sapienza University of Rome and is the author of dozens of peer-reviewed articles in international journals. He is currently associated researcher at Sony CSL Paris.
https://wn.com/Ranking_Effectiveness_Of_Worldwide_Covid19_Government_Interventions_Alessandro_Londei_|_Etincelle_4
Assessing non-pharmaceutical interventions’ (NPIs) effectiveness to mitigate the spread of SARS-CoV-2 is critical to inform future preparedness response plans. We propose a modeling approach that combines four computational techniques merging statistical, inference, and artificial intelligence tools to evaluate the impact of NPIs on spreading the Covid19 pandemic. Our results indicate that a suitable combination of NPIs is necessary to curb the spread of the virus. Less disruptive and costly NPIs can be as effective as more intrusive, drastic ones (for example, a national lockdown). Using country-specific “what-if” scenarios, we assess how the effectiveness of NPIs depends on the local context, such as the timing of their adoption, opening the way for forecasting the effectiveness of future interventions.
Etincelle #4 - January 20, 2021
Alessandro Londei has a degree in Physics and a PhD in Electronic Engineering and Computer Science at the Sapienza University of Rome. During his professional career he has been involved in complex systems, neural networks, cognitive sciences and artificial intelligence. He held the courses of Neural Networks and Artificial Intelligence at the Sapienza University of Rome and is the author of dozens of peer-reviewed articles in international journals. He is currently associated researcher at Sony CSL Paris.
- published: 22 Jan 2021
- views: 169
1:52
How can we improve our model? | Modeling the Pandemic, chapter 3
The WAIFW Matrix image is from "Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales" by Pitman et al. (2011)
Fo...
The WAIFW Matrix image is from "Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales" by Pitman et al. (2011)
For more information on the WAIFW, see
https://www.amazon.com/Introduction-Infectious-Disease-Modelling-ebook/dp/B00DUDQ07G
https://wn.com/How_Can_We_Improve_Our_Model_|_Modeling_The_Pandemic,_Chapter_3
The WAIFW Matrix image is from "Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales" by Pitman et al. (2011)
For more information on the WAIFW, see
https://www.amazon.com/Introduction-Infectious-Disease-Modelling-ebook/dp/B00DUDQ07G
- published: 12 Mar 2020
- views: 573
10:55
Estimating the multiplicity of infection of P. falciporum malaria parasites
If you're unlucky enough to be infected by malaria, you might even be infected by multiple strains of malaria! So how can we monitor whether interventions again...
If you're unlucky enough to be infected by malaria, you might even be infected by multiple strains of malaria! So how can we monitor whether interventions against this deadly disease are working? This talk discusses a research collaboration between Emory University and the CDC about methods that might help.
https://wn.com/Estimating_The_Multiplicity_Of_Infection_Of_P._Falciporum_Malaria_Parasites
If you're unlucky enough to be infected by malaria, you might even be infected by multiple strains of malaria! So how can we monitor whether interventions against this deadly disease are working? This talk discusses a research collaboration between Emory University and the CDC about methods that might help.
- published: 09 Nov 2017
- views: 1558
1:09:52
The European Health Union & access to health technologies: is joint purchasing the way forward?
The European Health Union & access to health technologies: is joint purchasing the way forward?
Thursday, 10 February 2022 (12:00- 13:00 CET)
This 60-minute se...
The European Health Union & access to health technologies: is joint purchasing the way forward?
Thursday, 10 February 2022 (12:00- 13:00 CET)
This 60-minute session is the first of a European Health Union Initiative webinar series with the European Observatory on Health Systems and Policies, organised in close cooperation European Health Forum Gastein.
The enduring problem of ensuring sustainable and equitable access to affordable medicines and other health technologies for all has been highlighted once again during the COVID-19 crisis. In this upcoming webinar organised in close collaboration between the European Health Union initiative and the European Observatory on Health Systems and Policies, we will explore whether we can harness the recent experience of joint purchasing during the pandemic to better ensure equitable access to health technologies for diverse patient groups in the future.
We will consider:
regional voluntary collaborations for improving access to high-priced medicines such as the BeNeLuxA initiative and the Valletta Declaration;
the work planned under the multi-stakeholder Oslo Medicines Initiative;
contracts under the EU Joint Procurement Agreement for PPE, ventilators, laboratory equipment, therapeutic remdesivir, and ICU medicines during the COVID-19 pandemic;
the joint purchasing of COVID-19 vaccines using Advance Purchase Agreements with vaccine manufacturers through funds under the European Commission´s Emergency Support instrument.
In light of what we know from these different mechanisms, we will discuss the potential to adopt or adapt them for purchasing technologies beyond public health emergencies, such as very costly medicines. Join us on Thursday 10 February to discuss the opportunities and challenges of joint purchasing, and to assess the potential to adapt the current regulatory framework to achieve a fairer, more transparent and sustainable solution to this ongoing “wicked” problem!
Speakers:
Richard Bergström, Vaccine Coordinator, Government of Sweden
Anniek de Ruijter, Associate Professor of European Law, University of Amsterdam
Natasha Azzopardi-Muscat, Director of the Division of Country Health Policies and Systems, WHO Regional Office for Europe
Alexander Natz, Secretary General, EUCOPE
Charlotte Roffiaen, European Affairs Advisor, France Assos Sante
Moderators:
Dimitra Panteli & Erica Richardson, European Observatory on Health Systems and Policies
https://wn.com/The_European_Health_Union_Access_To_Health_Technologies_Is_Joint_Purchasing_The_Way_Forward
The European Health Union & access to health technologies: is joint purchasing the way forward?
Thursday, 10 February 2022 (12:00- 13:00 CET)
This 60-minute session is the first of a European Health Union Initiative webinar series with the European Observatory on Health Systems and Policies, organised in close cooperation European Health Forum Gastein.
The enduring problem of ensuring sustainable and equitable access to affordable medicines and other health technologies for all has been highlighted once again during the COVID-19 crisis. In this upcoming webinar organised in close collaboration between the European Health Union initiative and the European Observatory on Health Systems and Policies, we will explore whether we can harness the recent experience of joint purchasing during the pandemic to better ensure equitable access to health technologies for diverse patient groups in the future.
We will consider:
regional voluntary collaborations for improving access to high-priced medicines such as the BeNeLuxA initiative and the Valletta Declaration;
the work planned under the multi-stakeholder Oslo Medicines Initiative;
contracts under the EU Joint Procurement Agreement for PPE, ventilators, laboratory equipment, therapeutic remdesivir, and ICU medicines during the COVID-19 pandemic;
the joint purchasing of COVID-19 vaccines using Advance Purchase Agreements with vaccine manufacturers through funds under the European Commission´s Emergency Support instrument.
In light of what we know from these different mechanisms, we will discuss the potential to adopt or adapt them for purchasing technologies beyond public health emergencies, such as very costly medicines. Join us on Thursday 10 February to discuss the opportunities and challenges of joint purchasing, and to assess the potential to adapt the current regulatory framework to achieve a fairer, more transparent and sustainable solution to this ongoing “wicked” problem!
Speakers:
Richard Bergström, Vaccine Coordinator, Government of Sweden
Anniek de Ruijter, Associate Professor of European Law, University of Amsterdam
Natasha Azzopardi-Muscat, Director of the Division of Country Health Policies and Systems, WHO Regional Office for Europe
Alexander Natz, Secretary General, EUCOPE
Charlotte Roffiaen, European Affairs Advisor, France Assos Sante
Moderators:
Dimitra Panteli & Erica Richardson, European Observatory on Health Systems and Policies
- published: 11 Feb 2022
- views: 342
54:58
Columbia NLP Seminar (Liang Huang): Parsing Algorithms for COVID-19
Columbia University NLP Seminar, April 19, 2022 (missing the first 5 minutes of recording)
Two Sides of the Same Coin: Parsing Algorithms for COVID-19
Liang Hu...
Columbia University NLP Seminar, April 19, 2022 (missing the first 5 minutes of recording)
Two Sides of the Same Coin: Parsing Algorithms for COVID-19
Liang Huang (Baidu Research USA & Oregon State University)
Abstract: Linguistics and biology are seemingly very different, but they actually share the same mathematical foundations. In particular, many algorithms have been reinvented in both NLP and computational biology, including CKY and Inside-Outside. This talk will cover several success stories of applying efficient natural language parsing algorithms to speed up RNA biology, and showcase their impact on COVID-19.
We start by adapting the linear-time incremental parsing algorithm of Huang and Sagae (2010) to RNA folding, which results in LinearFold (2019), the first major speedup in RNA folding in 40 years. Since the pandemic, this algorithm is becoming popular where the excessive length of the SARS-CoV-2 genome (the longest RNA virus known today) renders all other folding algorithms impractical. Based on this, I further developed two parsing-inspired algorithms to directly fight COVID-19. The first one tackles mRNA vaccine design. Quite unexpectedly, we solved this problem by reducing it to the classical NLP concept of lattice parsing and our algorithm is now being used by 30+ vaccine companies worldwide. The second one uses synchronous parsing to align and fold SARS-CoV-2 variants, finding “Achilees heels’’ of its genomes (PNAS, 2021). In short, computational linguistics can and will save lives.
This talk is dedicated to the memory of my late advisor Aravind Joshi (1929–2017) who showed me this connection between linguistics and biology 20 years ago.
Bio:
Liang Huang (PhD, Penn, 2008) is an Associate Professor of Computer Science at Oregon State University and a Distinguished Scientist at Baidu Research USA. He is a leading theoretical computational linguist, and was recognized at ACL 2008 (Best Paper Award) and ACL 2019 (Keynote Speech), but in recent years he has been more interested in applying his expertise in parsing, translation, and grammar formalisms to biology problems such as RNA folding and RNA design, a direction his late advisor Aravind Joshi pioneered 20 years ago. Since the outbreak of COVID-19, he has shifted his attention to the fight against the virus, which resulted in efficient algorithms for stable mRNA vaccine design used by 30+ vaccine companies, and the first homologous folding algorithm to scale to SARS-CoV-2 variants (PNAS, 2021).
https://wn.com/Columbia_Nlp_Seminar_(Liang_Huang)_Parsing_Algorithms_For_Covid_19
Columbia University NLP Seminar, April 19, 2022 (missing the first 5 minutes of recording)
Two Sides of the Same Coin: Parsing Algorithms for COVID-19
Liang Huang (Baidu Research USA & Oregon State University)
Abstract: Linguistics and biology are seemingly very different, but they actually share the same mathematical foundations. In particular, many algorithms have been reinvented in both NLP and computational biology, including CKY and Inside-Outside. This talk will cover several success stories of applying efficient natural language parsing algorithms to speed up RNA biology, and showcase their impact on COVID-19.
We start by adapting the linear-time incremental parsing algorithm of Huang and Sagae (2010) to RNA folding, which results in LinearFold (2019), the first major speedup in RNA folding in 40 years. Since the pandemic, this algorithm is becoming popular where the excessive length of the SARS-CoV-2 genome (the longest RNA virus known today) renders all other folding algorithms impractical. Based on this, I further developed two parsing-inspired algorithms to directly fight COVID-19. The first one tackles mRNA vaccine design. Quite unexpectedly, we solved this problem by reducing it to the classical NLP concept of lattice parsing and our algorithm is now being used by 30+ vaccine companies worldwide. The second one uses synchronous parsing to align and fold SARS-CoV-2 variants, finding “Achilees heels’’ of its genomes (PNAS, 2021). In short, computational linguistics can and will save lives.
This talk is dedicated to the memory of my late advisor Aravind Joshi (1929–2017) who showed me this connection between linguistics and biology 20 years ago.
Bio:
Liang Huang (PhD, Penn, 2008) is an Associate Professor of Computer Science at Oregon State University and a Distinguished Scientist at Baidu Research USA. He is a leading theoretical computational linguist, and was recognized at ACL 2008 (Best Paper Award) and ACL 2019 (Keynote Speech), but in recent years he has been more interested in applying his expertise in parsing, translation, and grammar formalisms to biology problems such as RNA folding and RNA design, a direction his late advisor Aravind Joshi pioneered 20 years ago. Since the outbreak of COVID-19, he has shifted his attention to the fight against the virus, which resulted in efficient algorithms for stable mRNA vaccine design used by 30+ vaccine companies, and the first homologous folding algorithm to scale to SARS-CoV-2 variants (PNAS, 2021).
- published: 21 Apr 2022
- views: 398
11:51
Viruses and the Tree of Life
This video discusses viral infections, viral structure and the relationship of viruses to the tree of life. A mathematical model is used to predict when the tra...
This video discusses viral infections, viral structure and the relationship of viruses to the tree of life. A mathematical model is used to predict when the travel restrictions now in effect for the COVID-19 Corona Virus may be lifted.
Resources:
Johns Hopkins Coronavirus Resource Center
https://coronavirus.jhu.edu/map.html
Ben Sparks describes a model to predict the propagation of cornavirus (COVID-19).
https://youtu.be/k6nLfCbAzgo
https://wn.com/Viruses_And_The_Tree_Of_Life
This video discusses viral infections, viral structure and the relationship of viruses to the tree of life. A mathematical model is used to predict when the travel restrictions now in effect for the COVID-19 Corona Virus may be lifted.
Resources:
Johns Hopkins Coronavirus Resource Center
https://coronavirus.jhu.edu/map.html
Ben Sparks describes a model to predict the propagation of cornavirus (COVID-19).
https://youtu.be/k6nLfCbAzgo
- published: 31 Mar 2020
- views: 1550